The regulation of liver cytochrome P450 by the brain dopaminergic system

Current Drug Metabolism

Volumn 8, Issue 6, 2007, Pages 631-638

  Wójcikowski, Jacek ^a   Gołembiowska, Krystyna ^a   Daniel, Władysława Anna ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Brain dopaminergic system; Cytochrome P450; Liver; Regulation

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ANTIBIOTIC AGENT; ASCORBIC ACID; CAFFEINE; CALCIUM CHANNEL BLOCKING AGENT; CYTOCHROME P450; CYTOCHROME P450 1A; CYTOCHROME P450 2A; CYTOCHROME P450 2B; CYTOCHROME P450 2C; CYTOCHROME P450 2C11; CYTOCHROME P450 2C6; CYTOCHROME P450 2D; CYTOCHROME P450 3A; DESIPRAMINE; DOPAMINE; DRUG METABOLIZING ENZYME; ETHYLMORPHINE; HOMOVANILLIC ACID; ISOPROTEIN; OXIDOPAMINE; PSYCHOTROPIC AGENT; STEROID; TOXIN; UNCLASSIFIED DRUG; WARFARIN;

ANIMAL TISSUE; BRAIN DEPTH STIMULATION; BRAIN INJURY; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; GENE CONTROL; LIVER METABOLISM; LIVER MICROSOME; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PROTEIN ANALYSIS; RAT; RECEPTOR BLOCKING; REVIEW;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BLOTTING, WESTERN; BRAIN; BRAIN CHEMISTRY; CYTOCHROME P-450 ENZYME SYSTEM; DOPAMINE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HOMOVANILLIC ACID; ISOENZYMES; LIMBIC SYSTEM; LIVER; MALE; NEOSTRIATUM; OXIDOPAMINE; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; SYMPATHOLYTICS;

EID: 34547652315     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920007781368872     Document Type: Review

References (40)

1. Weiner, R.I. and Ganong, W.F. (1978) Physiol. Rev., 58, 905-976.
2. Palkovits, M.; Leranth, C.; Zaborszky, L. and Brownstein, M.J. (1977) Brain Res., 136, 339-344.
3. Smith, G.C.; Courtney, P.G.; Wreford, N.G.M. and Walker, M.M. (1982) Brain Res., 234, 101-110.
4. Fuller, R.W. and Snoddy, H.D. (1981) Endocrinology, 109, 1026-1032.
5. Mueller, G.P.; Simpkins, J.; Meites, J. and Moore, K.E. (1976) Neuroendocrinology, 20, 121-135.
6. Vijayan, E.; Krulich, L. and McCann, S.M. (1978) Neuroendocrinology, 26, 174-185.
7. Burk, O. and Wojnowski, L. (2004) Naunyn-Schmieeberg's. Arch. Pharmacol., 369, 105-124.
8. Pascussi, J.-M.; Gerbal-Chaloin, S.; Drocourt, L.; Fabre, J.M.; Maurel, P. and Vilarem, M.J. (2003) Biochim. Biophys. Acta, 1619, 243-253.
9. Iber, H.; Chen, Q.; Sewer, M. and Morgan, E.T. (1997) Arch. Biochem. Biophys., 345, 305-310.
10. Agrawal, A.K. and Shapiro, B.H. (2000) J. Pharmacol. Exp. Ther., 292, 228-237.
11. Pampori, N.A.; Agrawal, A.K. and Shapiro, B.H. (2001) Drug Metab. Dispos., 29, 8-16.
12. Liddle, C.; Goodwin, B.J.; George, J.; Tapner, M. and Farrell, G. (1998) J. Clin. Endocrinol. Metab., 83, 2411-2416.
13. Murayama, N.; Shimada, M.; Yamazoe, Y. and Kato R. (1991) Mol. Pharmacol., 39, 811-817.
14. Waxman, D.J.; Ram, P.A.; Notani, G.; LeBlanc, G.A.; Alberta, J.A.; Morrissey, J.J. and Sundseth, S.S. (1990) Mol. Endocrinol., 4, 447-454.
15. Daniel, W.A. (2005) Expert Opin. Drug Metab. Toxicol., 1, 203-217.
16. Murray, M. (1992) Biochem. Pharmacol., 44, 1219-1222.
17. Rane, A.; Liu, Z.; Levol, R.; Bjelfman, C.; Thyr, C.; Ericson, H. and Hansson, T. (1996) Biochem. Biophys. Acta, 1291, 60-66.
18. Saland, L.C. and Comunas, F. (1985) Neurosci. Lett., 57, 49-55.
19. Paxinos, G. and Watson, C. (1998) The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego.
20. Lowry, O.H.; Rosenbrough, N.J.; Farr, A.L. and Randall, R.J. (1951) J. Biol. Chem., 193, 265-275.
21. Gołembiowska, K. and Dziubina, A. (2004) Neuropharmacology, 47, 414-426.
22. Daniel, W.A.; Syrek, M.; Ryłko, Z. and Wójcikowski, J. (2001) Pol. J. Pharmacol., 53, 351-357.
23. Kot, M. and Daniel, W.A. (2005) Pharmacol. Rep., 57, 283.
24. Haduch, A.; Wójcikowski, J. and Daniel, W.A. (2006) Eur. Neuropsychopharmacol., 16, 178-186.
25. Daniel, W.A.; Haduch, A.; Syrek, M. and Boksa, J. (2006) Eur. Neuropsychopharmacol., 16, 580-587.
26. Daniel, W.A.; Haduch, A. and Wójcikowski, J. (2005) Eur. Neuropsychpharmacol., 15, 103-110.
27. Agid, Y.; Javoy-Agid, F. and Ruberg, M. (1987) Mov. Disord., 2, 166-230.
28. Nordstrom, A.-L.; Farde, L. and Halldin, C. (1992) Psychopharmacology, 106, 433-438.
29. Farde, L.; Nordstrom, A.-L.; Wiesel, F.-A.; Pauli, S.; Halldin, C. and Sedvall, G. (1992) Arch. Gen. Psychiatry, 49, 538-544.
30. Simon, H.; Le Moal, M. and Calas, A. (1979) Brain Res., 178, 17-40.
31. Ishii, T.; Nishimura, K. and Nishimura, M. (2006) J. Pharmacol. Sci., 101, 250-255.
32. Honkakoski, P. and Negishi, M. (2000) Biochem. J., 347, 321-337.
33. Pascussi, J.-M.; Gerbal-Chaloin, S.; Drocourt, L.; Assenat, E.; Larrey, D.; Pichard-Garcia, L.; Vilarem, M.-J. and Maurel, P. (2004) Xenobiotica, 34, 633-664.
34. Zelko, I. and Negishi, M. (2000) Biochem. Biophys. Res. Commun., 277, 1-6.
35. Choi, H.K. and Waxman, D.J. (2000) Endocrinology, 14, 3245-3255.
36. Oesch-Bartlomowicz, B. and Oesch, F. (2002) Biol. Chem., 383, 1587-1592.
37. Sŗée, E.; Villard, P.-H.; Pascussi, J.-M.; Pineau, T.; Maurel, P.; Nguyen, Q.B.; Fallone, F.; Martin, P.-M.; Champion, S.; Lacarelle, B.; Savouret, J.-F. and Barra, Y. (2004) Gastroenterology, s127, 1436-1445.
38. Hunter, J.; Kassam, A.; Winrow, C.J.; Rachubinski, R.A. and Capone, J.P. (1996) Mol. Cell. Endocrinol., 116, 213-221.
39. Miller, R.T.; Scappino, L.A.; Long, S.M. and Corton, J.C. (2001) Toxicol. Pathol., 29, 149-155.
40. Baum, L.O. and Strobel, H.W. (1997) Brain Res., 765, 67-73.